HNHAF(HNHAF)
HNHAF
No analyst ratings available
No analyst price targets available for HNHAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $10.91T | $14.54T | $18.45T |
| Low | $10.53T | $11.55T | $16.04T |
| High | $11.31T | $17.04T | $20.53T |
| EBITDA Avg | $531.06B | $666.55B | $785.66B |
| Low | $468.86B | $586.50B | $691.97B |
| High | $584.70B | $735.60B | $866.47B |
| EBIT Avg | $412.91B | $518.04B | $598.32B |
| Low | $350.71B | $437.98B | $504.63B |
| High | $466.55B | $587.08B | $679.13B |
| Net Income Avg | $263.86B | $339.63B | $397.49B |
| Low | $219.03B | $281.93B | $329.96B |
| High | $302.52B | $389.39B | $455.72B |
| EPS Avg | $18.67 | $24.03 | $28.13 |
| Low | $15.50 | $19.95 | $23.35 |
| High | $21.41 | $27.56 | $32.25 |
| Analysts (Rev / EPS) | 17 / 1 | 20 / 1 | 9 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2.87T | $3.42T | $3.24T | $3.66T | $3.84T | $4.38T |
| Low | $2.73T | $3.06T | $2.98T | $3.36T | $3.53T | $4.04T |
| High | $3.05T | $5.13T | $4.23T | $4.77T | $5.01T | $5.72T |
| EBITDA Avg | $144.25B | $165.34B | $151.42B | $166.45B | $179.00B | $196.82B |
| Low | $132.62B | $151.73B | $139.43B | $153.11B | $164.57B | $180.80B |
| High | $188.82B | $217.51B | $197.39B | $217.59B | $234.31B | $258.23B |
| EBIT Avg | $119.87B | $139.01B | $123.40B | $136.43B | $146.92B | $162.27B |
| Low | $108.25B | $125.40B | $111.41B | $123.09B | $132.49B | $146.25B |
| High | $164.44B | $191.18B | $169.37B | $187.58B | $202.23B | $223.68B |
| Net Income Avg | $80.85B | $94.65B | $83.40B | $92.79B | $100.35B | $111.41B |
| Low | $72.48B | $84.84B | $74.75B | $83.17B | $89.95B | $99.87B |
| High | $112.98B | $132.24B | $116.52B | $129.65B | $140.21B | $155.67B |
| EPS Avg | $4.94 | $5.78 | $5.09 | $5.67 | $6.13 | $6.81 |
| Low | $4.43 | $5.18 | $4.57 | $5.08 | $5.50 | $6.10 |
| High | $6.90 | $8.08 | $7.12 | $7.92 | $8.57 | $9.51 |
| Analysts (Rev / EPS) | 13 / 1 | 14 / 1 | 9 / 1 | 7 / 1 | 7 / 1 | 13 / 1 |